Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ballenger

Showing results (331-340 of 365) with videos related to

Pageof 37
Sort By:
The Journal of Clinical Psychiatry|May 18, 1999
Consensus statement on the primary care management of depression from the International Consensus Group on Depression and AnxietyJ C Ballenger, J R Davidson, Y Lecrubier, et al.
Depression and Anxiety|November 25, 2000
Bupropion-SR in treatment of social phobiaN P Emmanuel, O Brawman-Mintzer, W A Morton, et al.
Psychopharmacology Bulletin|January 1, 1993
Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorderR B Lydiard, W A Morton, N P Emmanuel, et al.
Biological Psychiatry|August 1, 1991
Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorderL S Austin, R B Lydiard, J C Ballenger, et al.
Inorganic Chemistry|June 8, 2024
Ternary Complexes of BiI<sub>3</sub>/CuI and SbI<sub>3</sub>/CuI with TetrahydrothiopheneJames H Ballenger, Katherine S Giunta, Ruby Carlson, et al.
Journal of Affective Disorders|January 1, 1989
Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatmentI M Lesser, R T Rubin, A Rifkin, et al.
Biological Psychiatry|November 18, 2000
A controlled trial of daily left prefrontal cortex TMS for treating depressionM S George, Z Nahas, M Molloy, et al.
Biological Psychiatry|April 1, 1995
A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorderM S Kramer, N R Cutler, J C Ballenger, et al.
Science (New York, N.Y.)|January 18, 1980
Schizophrenia: elevated cerebrospinal fluid norepinephrineC R Lake, D E Sternberg, D P van Kammen, et al.
Cancer Research|September 10, 1998
Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia markerJ A Raleigh, D P Calkins-Adams, L H Rinker, et al.
Pageof 37

Showing results (331-340 of 365) with videos related to

Sort By:
Pageof 37
The Journal of Clinical Psychiatry|May 18, 1999
Consensus statement on the primary care management of depression from the International Consensus Group on Depression and AnxietyJ C Ballenger, J R Davidson, Y Lecrubier, et al.
Depression and Anxiety|November 25, 2000
Bupropion-SR in treatment of social phobiaN P Emmanuel, O Brawman-Mintzer, W A Morton, et al.
Psychopharmacology Bulletin|January 1, 1993
Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorderR B Lydiard, W A Morton, N P Emmanuel, et al.
Biological Psychiatry|August 1, 1991
Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorderL S Austin, R B Lydiard, J C Ballenger, et al.
Inorganic Chemistry|June 8, 2024
Ternary Complexes of BiI<sub>3</sub>/CuI and SbI<sub>3</sub>/CuI with TetrahydrothiopheneJames H Ballenger, Katherine S Giunta, Ruby Carlson, et al.
Journal of Affective Disorders|January 1, 1989
Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatmentI M Lesser, R T Rubin, A Rifkin, et al.
Biological Psychiatry|November 18, 2000
A controlled trial of daily left prefrontal cortex TMS for treating depressionM S George, Z Nahas, M Molloy, et al.
Biological Psychiatry|April 1, 1995
A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorderM S Kramer, N R Cutler, J C Ballenger, et al.
Science (New York, N.Y.)|January 18, 1980
Schizophrenia: elevated cerebrospinal fluid norepinephrineC R Lake, D E Sternberg, D P van Kammen, et al.
Cancer Research|September 10, 1998
Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia markerJ A Raleigh, D P Calkins-Adams, L H Rinker, et al.
Pageof 37